[1] Hoffmann R G, Waid M E. The “average of normals” method of quality control [J]. Am J Clin Pathol, 43 (1965): 134-141. [2] Duan X, Wang B, Zhu J, et al. Assessment of patient-based real-time quality control algorithm performance on different types of analytical error[J]. Clin Chim Acta, 2020,511:329-335. [3] van Rossum H H. When internal quality control is insufficient or inefficient: Consider patient-based real-time quality control[J]. Ann Clin Biochem, 2020,57(3):198-201. [4] Bietenbeck A, Cervinski M A, Katayev A, et al. Understanding patient-based real-time quality control using simulation modeling[J]. Clin Chem, 2020,66(8):1072-1083. [5] Begtrup H, Leroy S, Thyregod P, et al.‘Average of normals' used as control of accuracy, and a comparison with other controls[J]. Scand J Clin Lab Invest, 1971,27(3):247-253. [6] 胥国强,康清秀,陈小东,等. 应用六西格玛原理分析临床生化项目的质量水平[J].重庆医学,2016,45(30):4279-4281. [7] 彭海,李子安,阿祥仁,等. 应用六西格玛管理方法评价临床常规生化检验项目的质量水平[J]. 国际检验医学杂志,2020,41(20):2544-2546. [8] Badrick T, Bietenbeck A, Katayev A, et al.Implementation of patient-based real-time quality control[J]. Crit Rev Clin Lab Sci, 2020,57(8):532-547. [9] 贾馨兰. 临床化学分析仪室内质量控制方法的评价和选择[J]. 中国保健营养,2016,26(16):139. [10]Badrick T, Cervinski M, Loh T P. A primer on patient-based quality control techniques[J]. Clin Biochem,2019,64:1-5. [11]Cembrowski G S, Chandler E P, Westgard J O. Assessment of “average of normals” quality control procedures and guidelines for implementation[J]. Am J Clin Pathol, 1984,81(4):492-499. [12]Hansen S I, Petersen P H, Lund F, et al. Separate patient serum sodium medians from males and females provide independent information on analytical bias[J]. Clin Chem Lab Med, 2017,55(12):1865-1872. [13]Fleming J K, Katayev A. Changing the paradigm of laboratory quality control through implementation of real-time test results monitoring: For patients by patients[J]. Clin Biochem,2015,48(7-8):508-513. [14]Smith F A, Kroft S H. Exponentially adjusted moving mean procedure for quality control. An optimized patient sample control procedure[J]. Am J Clin Pathol, 1996,105(1):44-51. [15]何书康,王薇,杜雨轩. 临床检验基于患者数据室内质量控制方法的研究与进展[J].国际检验医学杂志,2020,41(11):1390-1395. [16]刘小娟,黄亨建,李萍,等.罗氏试剂用于奥林巴斯全自动生化分析仪的潮源性分析[J].华西医学,2019, 19(3):401-402. [17]Mackay M, Hegedus G, Badrick T. A simple matrix of analytical performance to identify assays that risk patients using External Quality Assurance Program data[J]. Clin Biochem,2016,49(7-8):596-600. [18]臧素纲,韩霜,陈鑫,等. 浮动均值法用于生化分析仪室内质量管理方法的探讨[J]. 北京医学,2015,37(3):299-300. [19]Westgard J O. Intermal quality control: planningandimplementation strategies[J]. Ann Clin Biochem, 2003,40(Pt 6):593-611 [20]Kilgariff M, Owen J A. An assessment of the “average of normals” quality control method[J]. Clin Chim Acta, 1968,19(2):175-179. |